Search

Your search keyword '"Rodrigo-Troyano, A."' showing total 182 results

Search Constraints

Start Over You searched for: Author "Rodrigo-Troyano, A." Remove constraint Author: "Rodrigo-Troyano, A."
182 results on '"Rodrigo-Troyano, A."'

Search Results

1. Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia

2. Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia

3. Drug related problems in clinical practice: a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions

4. An international perspective on hospitalized patients with viral community-acquired pneumonia

5. Reduced airway levels of fatty-acid binding protein 4 in COPD: relationship with airway infection and disease severity

8. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study

10. Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study

11. Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients

12. Salivary immunity and lower respiratory tract infections in non-elite marathon runners.

13. Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia

18. Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia

20. Impact of Early Referral to Palliative Care in Patients with Interstitial Lung Disease

23. Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia

24. Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia

25. Correction to: Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study (European Journal of Clinical Microbiology & Infectious Diseases, (2020), 39, 8, (1513-1525), 10.1007/s10096-020-03870-3)

26. International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia

29. Antimicrobial peptides, disease severity and exacerbations in bronchiectasis

31. Correction to: Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective (BMC Infectious Diseases, (2018), 18, 1, (677), 10.1186/s12879-018-3565-z)

32. EARLY HOSPITAL READMISSION INCREASES SHORT AND LONG - TERM MORTALITY IN PATIENTS WITH INTERSTITIAL LUNG DISEASE

33. Drug related problems in clinical practice : a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions

34. Early hospital readmission increases short and long - term mortality in patients with interstitial lung disease

35. Drug related problems in clinical practice : a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions

37. Carga y factores de riesgo para la neumonía adquirida en la comunidad de Pseudomonas aeruginosa : un estudio multinacional de prevalencia puntual de pacientes hospitalizados

39. Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease Patients with Frequent Hospitalized Exacerbations: A Prospective Multicentre Study

40. Patógenos atípicos en pacientes hospitalizados con neumonía adquirida en la comunidad: una perspectiva mundial

41. Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease Patients with Frequent Hospitalized Exacerbations: A Prospective Multicentre Study

42. The respiratory threat posed by multidrug resistant Gram-negative bacteria

43. Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study

44. Bacteremic pneumococcal pneumonia is associated with an increased rate of cardiovascular events

46. Nonantibiotic Adjunctive Therapies for Community-Acquired Pneumonia (Corticosteroids and Beyond): Where Are We with Them?

47. Pseudomonas aeruginosaresistance patterns and clinical outcomes in hospitalized exacerbations of COPD

48. Airway Bacterial Load and Inhaled Antibiotic Response in Bronchiectasis

49. Airway FABP4 is decreased in COPD patients with airway bacterial infection

50. Pseudomonas aeruginosa en la enfermedad pulmonar obstructiva crónica; papel de los patrones de resistencia e impacto en las agudizaciones graves

Catalog

Books, media, physical & digital resources